MONICA LYNN: Open Payments
NPI 1205842861 · BLOOMSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 78 payments from 22 companies in 2025. Trend: 2023 $1,648 · 2024 $1,575 · 2025 $1,636
Food & beverage: $1,620Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $313 |
| AstraZeneca Pharmaceuticals LP | 9 | $276 |
| Novo Nordisk Inc | 13 | $256 |
| Exact Sciences Corporation | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Esperion Therapeutics, Inc. | 4 | $81 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Lilly USA, LLC | 3 | $60 |
| Abbott Laboratories | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
Products named: VRAYLAR, BREZTRI, Wegovy, FARXIGA, Kerendia, NEXLETOL, QULIPTA, UBRELVY.
Industry payments across PA — which companies pay providers there.
